Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126259021 | 12625902 | 1 | I | 20160126 | 20160208 | 20160805 | 20160805 | PER | US-ABBVIE-16P-163-1566811-00 | ABBVIE | 59.00 | YR | M | Y | 93.89000 | KG | 20160805 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126259021 | 12625902 | 1 | PS | VIEKIRA PAK | DASABUVIROMBITASVIRPARITAPREVIRRITONAVIR | 1 | Unknown | 3 TABS IN AM OF 12.5MG/75MG/50MG AND ONE 270.3MG TAB AT PM (2X/ DAY) | UNKNOWN | 206619 | TABLET | ||||||||
| 126259021 | 12625902 | 2 | SS | RIBASPHERE | RIBAVIRIN | 1 | Unknown | THREE 200 TABLETS TWICE A DAY IN THE MORNING AND AT NIGHT | AC06542 | 0 | 600 | MG | TABLET | BID | |||||
| 126259021 | 12625902 | 3 | SS | RIBASPHERE | RIBAVIRIN | 1 | Unknown | 400 MG IN THE MORNING AND 200 MG IN THE EVENING | AC06542 | 0 | TABLET | BID | |||||||
| 126259021 | 12625902 | 4 | C | DILTIAZEM HCL SR (DILTIAZEM HYDROCHLORIDE) | 2 | Unknown | 0 | 180 | MG | QD | |||||||||
| 126259021 | 12625902 | 5 | C | FLECAINIDE | FLECAINIDE | 1 | Oral | 0 | 1 | DF | TABLET | BID | |||||||
| 126259021 | 12625902 | 6 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | 0 | |||||||||||
| 126259021 | 12625902 | 7 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126259021 | 12625902 | 8 | C | BABY ASPIRIN | ASPIRIN | 1 | Unknown | 0 | 81 | MG | QD | ||||||||
| 126259021 | 12625902 | 9 | C | XARELTO | RIVAROXABAN | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126259021 | 12625902 | 1 | Hepatitis C |
| 126259021 | 12625902 | 2 | Hepatitis C |
| 126259021 | 12625902 | 4 | Atrial fibrillation |
| 126259021 | 12625902 | 5 | Atrial fibrillation |
| 126259021 | 12625902 | 6 | Bone graft |
| 126259021 | 12625902 | 7 | Tooth extraction |
| 126259021 | 12625902 | 8 | Product used for unknown indication |
| 126259021 | 12625902 | 9 | Atrial fibrillation |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126259021 | 12625902 | Fatigue | |
| 126259021 | 12625902 | Headache | |
| 126259021 | 12625902 | Irritability | |
| 126259021 | 12625902 | Pruritus | |
| 126259021 | 12625902 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126259021 | 12625902 | 1 | 20151130 | 0 | ||
| 126259021 | 12625902 | 2 | 20151130 | 0 |